A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
Titel:
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
Auteur:
Sundström, Johan Kristófi, Robin Östlund, Ollie Bennet, Louise Eliasson, Björn Jansson, Stefan Leksell, Janeth Almby, Kristina Lundqvist, Martin Eriksson, Jan W.